Therapy for hepatitis C genotype 3: moving forward

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|9|683-690

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.9, 2015-09, pp. : 683-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1047-1058

John Wiley & Sons Inc

Access to resources Recommend Favorite

Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection

By  

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1047-1058

John Wiley & Sons Inc

Access to resources Recommend Favorite

P112: Hepatitis C virus NS3 polymorphism Q80K in genotype 1 therapy‐naive Brazilian patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 77-77

John Wiley & Sons Inc

Access to resources Recommend Favorite

The accuracy and cost‐effectiveness of hepatitis C core antigen assay in the monitoring of anti‐viral therapy in patients with chronic hepatitis C genotype 4

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 307-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations in different regions of the genome of hepatitis C virus genotype 1b and association with response to interferon therapy

By        

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1438-1442

Spandidos Publications

Access to resources Recommend Favorite